Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,646 | -33,717 | -40,370 | -47,860 | -49,287 |
| Depreciation Amortization | 490 | 433 | 591 | 1,297 | 1,900 |
| Accounts receivable | -46,641 | N/A | 10 | 32 | 134 |
| Accounts payable and accrued liabilities | -2,178 | 1,656 | 690 | 162 | -536 |
| Other Working Capital | -34,011 | 22,048 | 2,616 | -2,298 | -1,476 |
| Other Operating Activity | 52,143 | 1,862 | 3,025 | 3,072 | 4,435 |
| Operating Cash Flow | $-44,843 | $-7,718 | $-33,438 | $-45,595 | $-44,830 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 17,900 |
| PPE Investments | -1,104 | -529 | -123 | -440 | -479 |
| Purchase Of Investment | -107,043 | -79,434 | -92,788 | -48,025 | -109,860 |
| Sale Of Investment | 104,098 | 78,444 | 63,900 | 73,174 | 125,790 |
| Other Investing Activity | 0 | 0 | 196 | 592 | 886 |
| Investing Cash Flow | $-4,049 | $-1,519 | $-28,815 | $25,301 | $34,237 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -152 | -833 | -11,817 |
| Common Stock Issued | 48,949 | 14,488 | 43,341 | 10,696 | 425 |
| Other Financing Activity | 0 | 0 | 15,138 | 11,750 | 13,938 |
| Financing Cash Flow | $48,949 | $14,488 | $58,327 | $21,613 | $2,546 |
| Beginning Cash Position | 20,158 | 14,907 | 18,833 | 17,514 | 25,561 |
| End Cash Position | 20,215 | 20,158 | 14,907 | 18,833 | 17,514 |
| Net Cash Flow | $57 | $5,251 | $-3,926 | $1,319 | $-8,047 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,843 | -7,718 | -33,438 | -45,595 | -44,830 |
| Capital Expenditure | -1,104 | -542 | -125 | -443 | -493 |
| Free Cash Flow | -45,947 | -8,260 | -33,563 | -46,038 | -45,323 |